George Coukos
George Coukos
Verified email at
TitleCited byYear
A global reference for human genetic variation
1000 Genomes Project Consortium
Nature 526 (7571), 68-74, 2015
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ...
Nature medicine 10 (9), 942-949, 2004
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang, JR Conejo-Garcia, D Katsaros, PA Gimotty, M Massobrio, ...
New England journal of medicine 348 (3), 203-213, 2003
Cancer immunotherapy comes of age
I Mellman, G Coukos, G Dranoff
Nature 480 (7378), 480-489, 2011
Regulatory CD4+ CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
EY Woo, CS Chu, TJ Goletz, K Schlienger, H Yeh, G Coukos, SC Rubin, ...
Cancer research 61 (12), 4766-4772, 2001
microRNAs exhibit high frequency genomic alterations in human cancer
L Zhang, J Huang, N Yang, J Greshock, MS Megraw, A Giannakakis, ...
Proceedings of the National Academy of Sciences 103 (24), 9136-9141, 2006
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Q Huang, K Gumireddy, M Schrier, C Le Sage, R Nagel, S Nair, DA Egan, ...
Nature cell biology 10 (2), 202-210, 2008
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
I Kryczek, M Banerjee, P Cheng, L Vatan, W Szeliga, S Wei, E Huang, ...
Blood, The Journal of the American Society of Hematology 114 (6), 1141-1149, 2009
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T reg cells
A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ...
Nature 475 (7355), 226-230, 2011
Laser-capture microdissection
V Espina, JD Wulfkuhle, VS Calvert, A VanMeter, W Zhou, G Coukos, ...
Nature protocols 1 (2), 586, 2006
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L Zhang, S Volinia, T Bonome, GA Calin, J Greshock, N Yang, CG Liu, ...
Proceedings of the National Academy of Sciences 105 (19), 7004-7009, 2008
Modulation of the antitumor immune response by complement
MM Markiewski, RA DeAngelis, F Benencia, SK Ricklin-Lichtsteiner, ...
Nature immunology 9 (11), 1225, 2008
T-regulatory cells: key players in tumor immune escape and angiogenesis
A Facciabene, GT Motz, G Coukos
Cancer research 72 (9), 2162-2171, 2012
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors
J Duraiswamy, KM Kaluza, GJ Freeman, G Coukos
Cancer research 73 (12), 3591-3603, 2013
Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A
JR Conejo-Garcia, F Benencia, MC Courreges, E Kang, ...
Nature medicine 10 (9), 950-958, 2004
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers
S Deng, X Yang, H Lassus, S Liang, S Kaur, Q Ye, C Li, LP Wang, ...
PloS one 5 (4), 2010
Deciphering and reversing tumor immune suppression
GT Motz, G Coukos
Immunity 39 (1), 61-73, 2013
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
RJ Buckanovich, A Facciabene, S Kim, F Benencia, D Sasaroli, K Balint, ...
Nature medicine 14 (1), 28-36, 2008
The system can't perform the operation now. Try again later.
Articles 1–20